Status:
COMPLETED
Prevalence of Molar Incisor Hypomineralization Among Children Treated With Asthmatic Drugs Early in Their Lives
Lead Sponsor:
Cairo University
Conditions:
Molar Incisor Hypomineralization
Asthma in Children
Eligibility:
All Genders
8-12 years
Brief Summary
The aim of this study is to assess the prevalence of molar incisor hypo mineralization among children who have been treated with asthmatic drugs during the first three years of life.
Detailed Description
The term Molar incisor hypo mineralization (MIH) was first introduced in 2001 as a developmental disorder of enamel characterized by hypo mineralization -of systemic origin - affecting the enamel of f...
Eligibility Criteria
Inclusion
- Children from 8 to 12 years old with fully erupted first permanent molars and permanent incisors.
- Children who were patients of the Pediatric Pulmonary Clinic and had used asthma drugs (oral and inhaled bronchodilators or corticosteroids) during their first three years of life.
Exclusion
- Children with any chronic disease
- Children with unerupted or partially erupted first permanent molars.
- Children using a fixed orthodontic appliance
- Children having extensive carious lesions that might mask dental enamel defects.
Key Trial Info
Start Date :
May 20 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2022
Estimated Enrollment :
167 Patients enrolled
Trial Details
Trial ID
NCT04103710
Start Date
May 20 2020
End Date
July 1 2022
Last Update
September 6 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Agouza police hospital
Giza, Egypt